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INTRODUCTION {#SEC1}
============

Telomeres protect the eukaryotic chromosomal ends against fusion, degradation and unwanted double-strand break repair mechanisms. The length and structure of telomeres is tightly controlled ([@B1]). Telomeric DNA is synthesized by telomerase, an enzyme not expressed in most somatic cells. In humans, the majority of cells lack telomerase activity and telomeres shorten gradually with each cell division. The accumulation of critically short telomeres leads to replicative senescence and eventual cell death. About 85--90% of primary tumors re-express telomerase activity, thereby enabling those cells to become immortal by maintaining their telomere length ([@B2]). Thus, understanding the mechanisms that maintain telomere length can have substantial medical implications, in particular for ageing and carcinogenesis. *Saccharomyces cerevisiae* is a well studied model organism with an active telomerase enzyme ([@B3]). Telomerase of *S. cerevisiae* is comprised of the RNA template, TLC1, and the 'Ever shorter telomere' proteins Est1, Est2 and Est3. Est2 is the catalytic subunit of telomerase, while Est1 and Est3 are TLC1-RNA-associated proteins ([@B4]). Cdc13 (Est4) is a sequence-specific telomere-DNA-binding protein, involved in telomere capping to protect the chromosomal ends from degradation and it interacts with Est1 to recruit the telomerase complex ([@B2]).

The yeast genome has close to 6000 recognized genes. By systematically deleting each individual non-essential gene, a collection of 4700 mutants (knockouts) was established \[non-essential yeast mutant collection ([@B5])\]. This collection was later complemented by two additional libraries of mutants of all the essential genes (yeast has ∼1300 essential genes) whereby either hypomorphic ([@B6]) or temperature-sensitive alleles ([@B7]) of the genes were created. Systematic mutant screens can be carried out with these mutant collections even if the phenotype of interest is not selectable. Genome-wide screening efforts resulted in a comprehensive list of genes that, when mutated, affect telomere length in *S. cerevisiae* ([@B8]). These systematic screens revealed that ∼8% of the genes within the yeast genome affected (either directly or indirectly) telomeric length homeostasis. Indeed, a total of ∼500 of such telomere-length maintenance (*TLM*) genes were identified. About 60% of the identified *TLM* genes lead to short telomeres when mutated compared to the wild-type and the other 40% to elongated telomeres. TLM proteins have many different biochemical functions and localize to several compartments in the cell. Most of these were not known to play a role in homeostasis of telomere length, and their mechanism of action is only now starting to be studied.

In this study, we followed a computational approach and used this phenotypic information (aberrant telomere length) as a starting point to elucidate the transcriptional regulation of the telomerase holoenzyme. *TLC1* was excluded from the analysis because no expression data was available. To predict the effect of putative regulators (transcription factors, chromatin modifiers) of the telomerase genes, we followed a Mixed Integer Linear Programming (MILP) approach we developed recently ([@B13]). MILP can be used as a powerful linear regression method. Compared to a lasso regression approach, the most prominent advantages of an MILP-based regression are that the error penalties are linear avoiding over-emphasizing outliers (L1 regression) and MILP allows integrating binary switches or discrete constraints \[for details, see ([@B13])\]. We constructed regulatory models using the MILP approach and a comprehensive set of gene expression profiles of deletion strains of *S. cerevisiae* ([@B14],[@B15]). To restrict the TLM list to those that are expected to impact on telomere length through a direct regulation of the *EST* genes, we focused on deletion strains of transcriptional regulators that lead to telomere shortening (short *tlms*). Putative binding interactions were inferred from ChIP experiments of regulators binding to their targets \[taken from the database YEASTRACT ([www.yeastract.com](http://www.yeastract.com)) and ([@B16])\]. To select the regulators being relevant specifically for telomere maintenance (and the corresponding telomere phenotype), we set up a discriminative machine learning algorithm and studied the regulation of the *EST* genes in regulator deletion strains with aberrant telomere length (short *tlm* mutants) compared to regulator deletion strains with normal telomere length (non-TLM genes or controls). We identified genes affecting histone levels and modifications as the main regulators of telomerase transcription in yeast, and we identified the transcription factors Sum1, Hst1 and Srb2 as most promising hits regulating *EST1*.

MATERIALS AND METHODS {#SEC2}
=====================

Gene expression data {#SEC2-1}
--------------------

We used published microarray gene expression data of 269 yeast regulator deletion strains (strains BY4741, S288C and BYTET). This dataset was originally generated by Hu *et al*. and consisted of 588 two-color cDNA microarray hybridizations of 269 regulator mutants against a reference sample ([@B14]). The dataset of Hu *et al*. was re-analyzed by Reimand *et al*. ([@B15]), and we used the data from the latter. Briefly, all probes on the arrays which were not annotated as open reading frames were removed. For duplicated and triplicated probes the average was calculated. The re-analysis included a variance stabilizing normalization ([@B15],[@B17]). Altogether, this pre-processed dataset of Reimand *et al*. consisted of expression values of 6253 protein-coding genes for 269 regulator deletion strains and was taken from Array Express (E-MTAB-109, [www.ebi.ac.uk/arrayexpress/](http://www.ebi.ac.uk/arrayexpress/)). For our model, we performed a *z*-score transformation for each gene across the whole dataset. To annotate each deletion strain as a deletion of a *TLM* gene, we used the results from ([@B8]) yielding knockout samples for 18 *tlm* mutants showing shortened telomeres (short *tlm* mutants), 11 showing elongated telomeres (long *tlm* mutants) and 240 non-*TLM* controls (normal telomere length) (Supplementary Table S1).

Constructing the regulatory network {#SEC2-2}
-----------------------------------

To identify regulators of the *EST* genes, we first constructed a regulatory network consisting of 6728 nodes and 203 234 edges between 382 regulators and 6346 target genes. The network based on the binding information taken from the YEAst Search for Transcriptional Regulators And Consensus Tracking (YEASTRACT) database ([www.yeastract.com](http://www.yeastract.com)) and a study of Yu and Gerstein ([@B16]). To date (August 2015), YEASTRACT bases on more than 1300 publications. We used only YEASTRACT entries annotated as 'documented' (DNA binding plus expression evidence) from high-throughput chromatin immunoprecipitation assays (ChIP-on-ChIP) and *in silico* refinements of this data ([@B15],[@B18],[@B19]). In addition, we used binding information from the study of Yu and Gerstein, who studied hierarchical structures in gene regulatory networks of yeast ([@B16]). In the following, these putative regulatory interactions of our regulatory network are denoted as 'known binding', the respective regulators 'putative regulators' and the targets 'putative targets'.

Modeling *EST* regulation {#SEC2-3}
-------------------------

Typically several regulators bind to a gene\'s promoter, each contributing to the expression of the target gene ([@B13],[@B20]). We used a MILP approach to predict gene expression of *EST* genes to (i) address additive cooperativity; and (ii) to select the most relevant regulators of the *EST* genes.

As depicted in Supplementary Figure S1, the model contained the three *EST* genes regulated by n regulators R~1~-R~n~. The predicted gene expression value $\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$\tilde g_{ik}$\end{document}$ was calculated as: $$\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}\begin{equation*} \tilde g_{ik} = \beta _0 + \sum\nolimits_{t = 1}^T {\beta _t *es_{ti} *act_{tk} } \end{equation*}\end{document}$$ where, *β*~0~ was an additive offset, *T* the number of all investigated regulators, *β*~t~ was the optimization parameter for regulator *t, es~ti~* was the edge strength between regulator *t* and its putative target gene *i* and *act~tk~* the activity of regulator *t* in sample *k*. To model strain specific effects of a regulator, the activity was calculated as: $$\documentclass[12pt]{minimal}
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}{}\begin{equation*} act_{tk} = \frac{{\sum\nolimits_{i = 1}^n {es_{ti} *|g_{ik} |} }}{{\sum\nolimits_{i = 1}^n {es_{ti} } }}. \end{equation*}\end{document}$$*act~tk~* was the estimated effect of regulator *t* in strain *k, es~ti~* the edge strength between regulator *t* and gene *i, g~ik~* the gene expression of gene *i* in strain *k*. Equation ([2](#M2){ref-type="disp-formula"}) defines the activity based on the cumulative effect of a regulator on all its target genes, normalized by the sum of all target genes to balance regulators with high and low numbers of targets. As regulators may be post-transcriptionally regulated, we didn\'t use the expression values of a regulator to estimate their sample specific effect. Instead, similar to Balwierz *et al*. ([@B26]), we estimated the activity of a regulator in a deletion strain by the differential expression of their putative target genes. The basic idea is that a regulator is more likely to be active in the specific sample if the putative targets are differentially expressed. The edge strength *es~ti~* was the edge weight between the regulators and the target genes. It was equal to 1 if gene *i* was reported to be a target of regulator *t* (known-binding, selected from YEASTRACT), and was zero otherwise.
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Because the linear optimizer could not handle absolute values, the absolute values were transformed into two inequalities for each gene *i* and knockout sample *k*, $$\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}\begin{equation*} g_{ik} - \tilde g_{ik} - e_{ik} \le 0 \end{equation*}\end{document}$$$$\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}\begin{equation*} - g_{ik} + \tilde g_{ik} - e_{ik} \le 0. \end{equation*}\end{document}$$

To solve this optimization problem we used the optimizer Gurobi ([www.gurobi.com](http://www.gurobi.com), version 6.0--6.04). To gain a representative variety of models with different sizes, we constructed models constraining the number of regulators. For each *EST* gene, models were constructed starting by one regulator up to a maximum of *n*-2 putative regulators (with known binding), where *n* was the number of samples. After constraining the number of regulators, the prediction error was minimized by the optimizer \[Equation ([3](#M3){ref-type="disp-formula"})\]. To gain an objective estimate for the performance and to circumvent overfitting, we performed cross-validation and resampling (see next section). The prediction performance of our model was estimated by the correlation between the measured (from the validation sets) and the predicted gene expression value (gained from the training sets).

The machine learning approach {#SEC2-4}
-----------------------------

A schematic overview of the workflow is given in Figure [1](#F1){ref-type="fig"}. To predict the transcript levels of each *EST* gene in the knockout strains which affect telomere length, we divided the dataset into data from knockout strains that showed short telomeres (short *tlm* mutants), long telomeres (long *tlm* mutants) and a control dataset showing normal telomere length. We mainly focused on the short telomere phenotype, because telomere elongation is an important hallmark of cancerogenesis. This resulted in a dataset of 18 short *tlm* mutants and 240 control knockout samples. For each target gene (*EST1, EST2, EST3*), we performed a ten-times sixfold cross-validation. Explicitly, the algorithm proceeded as follows:

i.  We randomly selected 120 datasets of all control samples (drawing with replacement).

ii. Datasets of the 18 short *tlm* mutants as well as of the 120 control samples were randomly divided into six equally sized partitions. Five sixths (15 short *tlm* samples, 100 controls) were used to train the regulatory model and the remaining sixth was used to validate the predictions.

iii. The modeling was done separately for the short *tlm* mutants and the control datasets. To obtain solutions of a large range of model sizes, we generated models of different sizes: we started with constraining the models to use only one regulator, i.e. the number of β-parameters was limited to a maximum of two (β~0~ and one β for the optimal regulator).This was repeated increasing the limit by one, now allowing one more β-parameter to be used by the model.Step (b) was repeated until the allowed number of β-parameters reached eleven (for 10 regulators with known binding information to the target gene, plus β~0~).For each number of regulators we further did a fivefold inner cross-validation, which means the training dataset was divided into fifths and four fifths were used to determine the combination of regulators (training phase of the model) and the remaining one fifth to test the performance of the combination. The combination with the best performance was then used for the remaining steps.Running (a) to (c) yielded two lists of selected regulators, one list for the short *tlm* mutants, and one list for the controls.

iv. Steps (ii) and (iii) were repeated six times covering all possible partitions to be training sets.

v.  To estimate the performance of the models, we used the validation datasets and calculated the Pearson correlation of the predicted gene expression values (basing on the β-parameters yielded from the training sets) and the real expression values of the validation datasets from all six runs.

vi. Steps (ii) to (v) were one cross-validation, and we repeated these steps ten-times.

vii. For the control samples, steps (i) to (vi) were repeated ten-times to cover their large variety.

![Schematic overview of the computational workflow. Using the expression profiles of short *tlm* knockout mutants as well as randomly selected control samples, a cross-validation was performed employing our linear modeling approach (inner loop for parameter optimization not shown). A significance test was performed to identify significant regulators being highly relevant for explaining expression of short *tlm* knockouts, while being not relevant for the controls.](gkw111fig1){#F1}

For each *EST* gene, altogether 60 different models were constructed for the short *tlm* mutants and 600 for the control samples. For each model, we counted how often each regulator was selected by the optimizer. With these distributions we did a one-sided Wilcoxon Test for each regulator in the list to identify significantly different regulators between the short *tlm* mutants and the control samples. Significant levels (*P*-values) were corrected for multiple testing using the Benjamini--Hochberg method ([@B27]).

Analyzing regulator activity correlation {#SEC2-5}
----------------------------------------

To identify potential false negatives, we calculated the Pearson correlation between the activities of all pairs of regulators (t, t') of the *EST* genes across the investigated samples. This was done separately for the dataset of short *tlm* mutants and the controls and led to two correlation matrices, one for each dataset, which we called TxT matrices. To get regulators that were active specifically in the short *tlm* mutants, we subtracted the TxT matrix of the controls from the TxT matrix of the short *tlm* mutants leading to a differential TxT matrix. All matrices can be found in the Supplementary Material (Supplementary Table S4). Additionally, we also calculated the correlation between the activity of all putative regulators (with known binding information) of each *EST* gene and the gene expression values of the corresponding *EST* gene, again separately for the short *tlm* mutants and the controls to get further hints for regulators which may have been disregarded in the modeling. The regulators were ranked by their correlations for both datasets and also for the correlation differences between the datasets. The results were then compared to the significant regulators obtained by our modeling and to the top entries of the differential TxT matrix to identify additional (potentially false negative) regulators.

Co-regulation {#SEC2-6}
-------------

To identify regulators with synergistic effects (complex partners, similar activity values), we simulated regulator knockouts by disregarding the edge between the regulator and the target gene. We then calculated models for the short *tlm* samples and the control dataset as described above (\'The machine learning approach\'). This was done exemplarily for Hst1 and Sum1. We further constructed models mimicking cooperative activity as described elsewhere ([@B28]) calculating the geometric mean. The activity of the combination Sum1_Hst1 was calculated by $$\documentclass[12pt]{minimal}
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Experimental validation: *EST1* expression analysis {#SEC2-7}
---------------------------------------------------

Yeast RNA was extracted as described previously ([@B29]). The RNA was DNase I treated for 1 h at 37°C using the RNase-Free DNase Set (QIAGEN). A total of 3 μg RNA of wild-type cells (BY4741 Mat a, BY4742 Mat α) and *sum1* mutants of both strains have been reverse transcribed with oligodT~12--18~ (12.5 ng/μl) following the protocol of the Superscript III RT Kit (Invitrogen). Respective minus-RT controls were used to assess the DNA backgrounds. The cDNA was diluted 2.5 times in H~2~O and analyzed by qPCR with the DyNAmo Flash SYBR Green qPCR Kit (Thermo Scientific) in technical triplicates: 10 min at 95°C, 35 cycles of 15 s at 95°C and 1 min at 60°C. qPCR-primers have been used at a final concentration of 500 nM (*EST1-FWD*: GCT GCC ACA ATG GGA AGT TTC G; *EST1-REV*: TGC CAG GAG GGT TTG ATG ACG; *ACTIN-FWD*: CCC AGG TAT TGC CGA AAG AAT GC; *ACTIN-REV*: TTT GTT GGA AGG TAG TCA AAG AAG CC). The *EST1* values were normalized to *ACTIN* expression (ΔCt method). The expression (2^−delta\ Ct^) of *EST1* in *sum1* mutants relative to the respective wild-type strain (Mat a/α) is displayed for three biological replicates (Figure [2](#F2){ref-type="fig"}). Two-tailed unpaired *t*-tests with Welch\'s correction were performed to test for significant differences.

![Expression of *EST1* in *sum1* deletion strains of both mating-types (left: mating-type a; right: mating-type α) compared to the wild-type (measured by RT-qPCR). The expression values are given relative to the control (actin). The error bars indicate the standard error (SEM) over the three replicates. Two-tailed unpaired *t*-tests with Welch\'s correction were performed to test for significant differences.](gkw111fig2){#F2}

RESULTS {#SEC3}
=======

Rationale {#SEC3-1}
---------

The *TLM* network represents a potentially useful target for anticancer therapy, as telomere length maintenance is a pre-requisite for the constant growth of cancer cells. In particular, we were interested in transcriptional regulators that lead to short telomeres when deleted (abbreviated as 'short *tlm* mutants' in the following). These mutants are defective for positive regulators of telomere elongation and have a high chance to modulate the expression of the *EST* genes, which encode the telomerase complex. Thus, we investigated regulator knockout strains which were short *tlm* mutants and analyzed their effects on the expression of the *EST* genes. As samples for the modeling we used yeast deletion strains of transcription factors or chromatin modifiers. These deletion strains were then divided into a short *tlm* dataset and a control dataset (and later also a long *tlm* dataset was used, see below). The sample sizes and their overlaps between the *TLM* genes, the regulator deletion strains and the putative regulators are shown in a Venn diagram (Supplementary Figure S2). The workflow for our study is depicted in Figure [1](#F1){ref-type="fig"}. We assumed that *TLM* genes that, when mutated, result in short telomeres, may participate in a transcriptional network culminating in the expression changes of the *EST* telomerase components. To identify specific regulators best explaining Est transcript levels in the short *tlm* knockout strains, we constructed linear models for each *EST* gene. The task for the linear models was to predict the gene expression of each *EST* gene in each sample using activity information (for each specific sample) of putative regulators. Putative regulators were selected from a database according to experimental evidence of the regulator\'s binding to the promoter of the *EST* gene (listed in Supplementary Table S2). We note that the calculated sample specific activity of a regulator is based on the cumulative differential expression of the regulator in the according sample. The models were optimized to select regulators which led to the best prediction of *EST* gene expression in each sample. This procedure was done twice, i.e. for the expression data of the short *tlm* knockout mutants, and for the expression data of the controls. We calculated models of different complexity for each dataset (short *tlm* knockout strains and the controls) employing cross-validation. From all these different runs, we counted how often each regulator was selected by the optimized models. This yielded two lists of regulator counts, one list for the short *tlm* mutants and one for the controls. To find regulators specifically explaining the regulation of *EST* genes in the short *tlm* knockout strains, the frequency of each regulator (Supplementary Figure S3) was compared between the short *tlm* mutants and the models for the controls. Performing a test of significance for each putative regulator led to the identification of regulators that specifically affect *EST* expression in the short *tlm* knockout mutants.

Investigating the predictions of the model {#SEC3-2}
------------------------------------------

Running our models as described above yielded 32 significant regulators for Est1, Est2 and Est3, respectively (Table [1](#tbl1){ref-type="table"}). The models were learned on training data. To estimate their performances, we used independent validation data for which we calculated the correlation of the modeled predicted expression values and the experimental expression values. For the models predicting Est1 regulators, we got a good overall Pearson correlation coefficient (PCC) of *r* = 0.51, for Est2 and Est3 the performance was lower (*PCC r* = 0.30 and *r* = 0.12, respectively). All correlations were highly significant (for all: *P* \< 2.2 E-16; more details on performance estimates and model statistics, see Text S1 in the Supplementary Material). In the following, we focus on predicted regulators with a high impact on the expression of the predicted *EST* targets, i.e. we selected predicted regulators with less than 1000 putative targets and a strong knockout effect (absolute *z*-score \> 1) or regulators which are *TLM* genes. For each *EST* gene, the main regulators detected are marked in bold in Table [1](#tbl1){ref-type="table"} (expression values are given by *z*-scores, also in the following). A high value of expression indicates an upregulation of the *EST* gene when the regulator was knocked out. This suggests an inhibitory effect of the regulator. Downregulation, in contrast, suggests an activating effect of the regulator. Interestingly, several of the regulators identified in our study are by themselves *TLM* genes, and when mutated affect telomere length. Regulators that cause short telomeres when mutated ([@B8],[@B10]) were Sum1, Hst1, Srb2 and Sin3 and are marked in red in Table [1](#tbl1){ref-type="table"}. One of the regulators of *EST3* (Dig1, blue in Table [1](#tbl1){ref-type="table"}), causes telomere elongation when deleted ([@B10]). To investigate if aberrant telomere length in general is putatively due to transcriptional regulation, we also investigated our models feeding them with expression data of short and long *tlm* mutants. Again, we compared the results to the control samples. Consistently, we yielded quite similar results as using the data of only the short *tlm* mutants (see Supplementary Table S3).

###### Significant regulators of *EST* genes

  ---------------------
  ![](gkw111tbl1.jpg)
  ---------------------

Regarding the results of the short *tlm* mutants, for *EST1*, we found Sum1 (*P* = 1.96 E-29), Hst1 (*P* = 1.96 E-29) and Srb2 (*P* = 1.14 E-7) to be highly significantly enriched in our predictions. For the predicted regulators, we investigated the literature (Pubmed, [www.ncbi.org](http://www.ncbi.org)) in the context of 'telomere', 'telomerase' and each of the *EST* gene symbols. Sum1 is a general chromatin silencing factor, as well as an initiation factor of replication. Furthermore, it is involved in the regulation of middle-sporulation genes. Sum1 builds a complex with the sirtuin protein Hst1 and the protein Rfm1, repressing genes through histone deacetylation ([@B30]). The sirtuin family members Sir2 and Hst1 have been reported to show similarity with Sum1 in telomere maintenance because of their specific co-enriched binding sites and their interaction with Rap1, a protein binding at the telomeric repeat regions ([@B30]). Srb2 is a subunit of the RNA polymerase II mediator complex. It is either directly involved in TLC1 transcription or indirectly in TLC1 accumulation ([@B34]). In the data we analyzed, Sum1 influenced the regulation of *EST1* most strikingly: for the *sum1* knockout strain, *EST1* showed the highest expression level among all knockout mutants investigated (*z*-score = 6.85, log-fold change = 0.93, see also Supplementary Figure S4a). *EST1* expression was also distinctively upregulated in the *hst1* (*z*-score = 3.61) and *srb2* knockout mutants (*z*-score = 2.08). In summary, Sum1, Hst1 and Srb2 are very likely to regulate *EST1* by inhibition. This result is unexpected, as strains deleted for *SUM1, HST1* or *SRB2* exhibit short telomeres (see 'Discussion' section). We experimentally validated this new finding exemplarily with Sum1 (see next section). Gln3 is the only significant regulator of *EST2* fulfilling the *z*-score and the target number criteria. Gln3 is involved in Tor Complex 1 regulated telomere shortening upon starvation by controlling the level of the Ku heterodimer ([@B35]). For *EST3*, the regulators Ume6, Sin3, Srb2, Hir1 and Dig1 were highly significant. Sin3 interacts with Rpd3 and Rpd2 to form histone deacetylase complexes. It is involved in the transcriptional repression and activation of diverse processes ([@B36]). Sin3 plays a role in silencing, repair of DNA double-strand breaks, and telomere length maintenance. In the complex with Rpd3, Sin3 affects silencing at the telomeres ([@B36]). Ume6 is another interactor of Rpd3 and a key regulator of early meiotic genes. It is involved in chromatin remodeling and in the recruitment of Sin3 and Rpd3 subunits of the histone deacetylase complex ([@B37]). Thus, our approach identified two different proteins of the Rpd3-based histone deacetylase complexes. In summary, our machine learning based linear modeling predictions identified mainly regulators involved in the regulation of chromatin and histone modifications.

Experimental validation of the predicted effect of Sum1 on *EST1* expression {#SEC3-3}
----------------------------------------------------------------------------

Because the *sum1* deletion strain showed the highest effect on *EST1* expression (Supplementary Figure S4a) and was a distinctively significant hit of our predictions, we investigated gene expression of *EST1* in the wild-type and the *sum1* mutant. Because Sum1 is involved in mating-type regulation ([@B38]), the expression of *EST1* was measured for *sum1* mutants of both mating types, Mat a and Mat α, by RT-qPCR. The results are shown in Figure [2](#F2){ref-type="fig"}. For both *sum1* mutants, *EST1* was highly upregulated (4.37-fold ± 0.67 SEM for Mat a and 6.00-fold ± 0.48 SEM for Mat α). This high upregulation of *EST1* in the *sum1* mutants observed by individual PCR is comparable to our observation of the investigated microarray gene expression data ([@B15]), which we used for our modeling analysis. In summary, we could show that the *sum1* knockout has a strong repressive effect on the expression of *EST1*.

Correlation analysis between regulator activities and *EST* expression {#SEC3-4}
----------------------------------------------------------------------

If the activity of a regulator was very similar to the activity of another regulator in each of the investigated samples, the model may have difficulties distinguishing between them and may neglect one of these regulators causing false negatives. To identify such potential false negatives, we calculated the correlation between all regulator activities (Supplementary Table S4) as well as between the regulator activities and the expression of the *EST* genes (Supplementary Tables S5--S7). This was done separately for the short *tlm* mutants and the controls, and the regulators with the largest differences were selected to obtain short *tlm* mutant specific regulators (Supplementary Table S8 shows the selected candidates, Supplementary Table S4 contains the correlations of activities of all potential pairs of regulators of short *tlm* mutants, controls and the differences, for details of this analysis, see Text S2 in the Supplementary Material). For *EST1* and *EST2* no further regulators were found. Interestingly, we found good correlation of Sum1 and Hst1 suggesting a cooperativity which was supported by a model for this (details, see Supplementary Text S3). For *EST3*, we found Gln3 as a potential further regulator with similar activity and expression correlation as Dig1 (Supplementary Tables S7 and S8).

Software implementation and availability {#SEC3-5}
----------------------------------------

The method is implemented within the software package MIPRIP for R ([www.r-project.org](http://www.r-project.org)). It is freely available at <http://www.leibniz-hki.de/en/miprip.html>. MIPRIP is platform independent and runs on R version 3.1.2 together with RStudio version 0.98.1103 and Gurobi version 6.0.4. Instead of solving the Mixed Integer Linear Models directly, all analyses were implemented in R using the Gurobi R API. MIPRIP uses the standard CRAN R package slam.

DISCUSSION {#SEC4}
==========

Telomere length needs to be precisely controlled during embryogenesis and for cancer cell immortalization. Central for this well balanced control is the transcriptional regulation of the telomerase, a protein complex encoded in *S. cerevisiae* by the three *EST* genes and *TLC1. S. cerevisiae* is a well suited model organism to study telomere biology of cancer cells as more than a quarter of all yeast genes have human homologs and the telomerase is constitutively expressed and functional in yeast ([@B3]). The candidate regulators we selected mainly based on ChIP-binding information. Hence, the regulators of the *EST* genes we used for the modeling are able to bind to the promoters of the target genes. To identify regulators best explaining the expression of the *EST* genes we used our previously developed linear modeling approach based on MILP ([@B13]). This method was embedded into a machine learning procedure to identify regulators that specifically regulate telomerase. Models of knockout strains showing short telomeres were compared to controls, hypothesizing that the absence of these regulators may directly influence telomerase expression and hence reduce telomerase activity. Although telomerase is regulated at various post-transcriptional levels and by many signaling processes, our aim was to find novel transcriptional regulators of telomerase. Hence, a hidden assumption of our approach was that transcription levels of the *EST* genes could be a limiting factor in telomere maintenance and we investigated *EST* expression of strains with knocked out regulators which by themselves are *TLM* genes that show abnormal telomere length when deleted. For *EST1*, our most prominent hits were Sum1 and Hst1. Sum1 is a general chromatin silencing factor. In a complex with Hst1 and Rfm1, it represses gene expression through histone deacetylation at their promoters. In the context of telomeres, Sum1 is known to be involved in telomere maintenance through an interaction with Rap1, similarly to sirtuins Sir2 and Hst1 ([@B30]). However, a role for Sum1 in directly regulating the expression of telomerase genes has not been reported so far. Furthermore, we identified Srb2 to be highly significant for *EST1* regulation. In addition, Gln3 is a significant regulator of *EST2* and Sin3, Dig1, Srb2, Hir1 and Ume6 are regulators of *EST3*. Similarly, no previous reports linked these regulators to the regulation of telomerase expression. *EST1* expression was highly upregulated in the *sum1, hst1* and *srb2* knockout strains (Supplementary Figure S4a); *EST2* was highly downregulated in the *gln3* mutant (Supplementary Figure S4b) and *EST3* was highly upregulated in the *ume6* mutant and downregulated in *sin3, srb2, dig1 and hir1* (Supplementary Figure S4c). The different effects of deleting *UME6* and *SIN3*, two genes that in meiosis usually act together to repress expression of meiotic genes ([@B39]) is surprising, although not unseen: previous work has shown that the repressive effect of Ume6 can be switched, so it can act as a positive regulator ([@B40],[@B41]). Our results suggest that Sum1 and Hst1 may act in combination in *EST1* regulation, consistent with the idea that they do so as part of the histone deacetylase complex they form together with Rfm1 ([@B30]). It was shown elsewhere that Rfm1 tethers Hst1 and Sum1 ([@B32]), hence it is likely that Rfm1 may be indirectly involved in *EST* regulation. Our quantitative RT-PCR results confirmed the upregulation of *EST1* in a *sum1* mutant, in line with the investigated microarray data from Reimand *et al*. ([@B15]). This implies a role for Sum1 in negatively regulating *EST1*. However, contrary to the expectations, deletion of *SUM1* leads to a *[short]{.ul}* telomere phenotype. We therefore speculated that high *EST1* expression may have a negative effect on telomere length. We investigated *EST1* expression in all 18 short *tlm* regulator knockouts and compared it with the non-*TLM* controls. Indeed, we found a significant difference (*P* = 0.047, Student\'s *t*-test): for the short *tlm* mutants the average expression of *EST1* was *z*-score = 0.78, while it was *z*-score = -0.056 for the control group. Thus, *EST1* seems to be upregulated in the short *tlms*. We speculate that excessive *EST1* may cause an imbalance between the subunits of the telomerase holoenzyme, limiting telomerase activity, for example by titration of factors important for telomerase activity, such as the RNA template Tlc1 or the recruiting factor Cdc13. Alternatively, it may bind to telomeres ([@B42]) and compete with functional complexes. Such a mechanism suggests a further role of Sum1 and Hst1 in telomere maintenance besides their role in Rap1 dependent telomeric recruitment ([@B30]).

Although to date the identified regulators had not been shown to regulate the telomerase complex directly on a transcriptional level, some of the regulators we found were reported to be involved in telomere maintenance (by e.g. chromatin remodeling). Thus, we hypothesize the existence of feed-forward loops strengthening the regulatory signal. Such feed-forward loops have been intensively investigated for cellular networks, as a way to improve signal to noise ratios as they respond to rather persistent signals ([@B43]). We suggest that Sum1 together with Hst1 and *EST1* form an incoherent feed-forward loop regulating telomere length, where Sum1/Hst1 and *EST1* positively regulate telomeres and Sum1/Hst1 negatively regulates *EST1* (Supplementary Figure S5) whose over expression may compromise normal telomere elongation activity.

In summary, we embedded our novel concept of linear regulation models based on MILP into a useful machine learning strategy which enabled us to identify novel regulators of the telomerase holoenzyme, where Sum1 is the most promising regulator of *EST1*.
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